Biotechnology News

May 29, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--"Launching Pharmaceutical Brands," a new study from Cutting Edge Information, finds that pharmaceutical brand teams are allocating larger slices of their marketing budgets to digital media this year...

May 29, 2012

WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention will look to highlight the role of academia in the advancement of the biotech field through the BIO Academic Park and the Translational Research Forum.

May 29, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTC BB: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has completed treatment of the third dosage...

May 29, 2012

MIAMI--(BUSINESS WIRE)--Baptist Health South Florida has been honored with five 2012 Partner for Change Awards from Practice Greenhealth, a national membership organization for healthcare facilities committed to environment.

May 29, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that management will present at two upcoming investor conferences: Mr. Vikas Sinha, Chief Financial Officer of Alexion, will present at the Jefferies...

May 29, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--The majority of surveyed rheumatologists believe that Pfizer’s tofacitinib has “a substantial” effect on signs and symptoms of RA as a monotherapy and in combination with DMARDS

May 29, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. psychiatrists indicate that they would prescribe Roche/Chugai’s...

May 29, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma announces positive results in a pivotal bioequivalence clinical trial with RHB-103, an oral thin-film formulation of Rizatriptan for the treatment of acute migraine.

May 29, 2012

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation has been issued an additional U.S. patent covering its AspirinWorks® technology. The patent increases the scope and variety of claims on the AspirinWorks Test Kit.

May 29, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Presentation Highlights Clinical Potential of Navidea Biopharmaceuticals’ β-Amyloid Imaging Biomarker AZD4694

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix to Webcast Its Presentation at 10th Annual Ardour Capital Energy Technology Conference

May 29, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced that in animal and in vitro studies, its tumor-targeting doxorubicin conjugate INNO-206 showed anti-multiple...

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, today announced that David...

May 29, 2012

CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for KYNAMRO™ (mipomersen sodium) for the treatment of patients with HoFH.

May 29, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, a privately held drug discovery tools and services company, announced today that it is launching a Discovery Services business to support growing demand for assay support on...

May 29, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Goldman Sachs 33rd Annual Healthcare...

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. will present at ASCO June 2,2012.

May 29, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Global Collaboration with Leading Academic Institutions to
Advance Science of Immuno-Oncology

May 29, 2012

STOCKHOLM--(BUSINESS WIRE)--Precise Biometrics' (http://www.precisebiometrics.com/)(STO:PREC) product for mobile security for smartphones and tablets,...

May 29, 2012

SEATTLE--(BUSINESS WIRE)--NanoString appointed Bruce J. Seeley as Senior Vice President & General Manager, Diagnostics to lead its newly formed Diagnostics business. Mr. Seeley was most recently EVP with Seattle Genetics.

May 29, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on June 5, 2012 at the Jefferies 2012 Global Healthcare Conference in New York City. The GTx presentation will begin at 1:30...

May 29, 2012

STOCKHOLM--(BUSINESS WIRE)--Precise Biometrics' (http://www.precisebiometrics.com/) product for mobile security for smartphones and tablets, Tactivo (...

May 29, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis completes enrollment in cervical cancer trial

May 29, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Jefferies 2012 Global Healthcare Conference, being held June 4-7, 2012 at the Grand Hyatt Hotel in New York City....

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex announced today a correction to the previously reported responder analysis, as well as additional data from, the recent interim analysis of an ongoing Phase 2 study of VX-809 and KALYDECO™.

May 29, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI) commences patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb® in healthy volunteers.

May 29, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three investment conferences during June 2012. Information regarding these conferences is provided below: Jefferies 2012...

May 29, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today announced that the Queensland Centre for Medical Genomics (QCMG), home of Australia’s International Cancer Genomics Consortium program, has established Illumina technology as its core...

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 3:00 p.m. (ET) in...

May 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--drug discovery collaboration with Genentech to discover macrocyclic drug candidates against targets specified by Genentech

May 29, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Cure for Traumatic Brain Injury May be in Sight

May 29, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ:SNTS) today announced that Gerald T. Proehl, president and chief executive officer, will make a presentation at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012, at 2:30 p...

May 29, 2012

GATWICK, England--(BUSINESS WIRE)--Consensus launched at European Wound Management Association's (EWMA) conference reveals guidelines on proper use of silver wound dressings

May 29, 2012

HAMBURG, Germany & CARLSBAD, Calif.--(BUSINESS WIRE)--European framework agreement outlining the terms for distribution by Olympus subsidiaries in Europe of ASI's GenASIs automated imaging platforms for genetic and pathological analysis.

May 29, 2012

TUSTIN, Calif.--(BUSINESS WIRE)--When opening a new hospital or medical center, partnering with the right diagnostic imaging vendor with patient-focused technology and a trusted, responsive service and support team is critical to meet the tight...

May 29, 2012

HATFIELD, United Kingdom--(BUSINESS WIRE)--EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa® (perampanel) as an adjunctive treatment of partial-onset seizure

May 28, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it will present at the Jefferies 2012 Global Healthcare Conference on Monday, June 4th at 9:30am Eastern Daylight Time (EDT), 2:30pm British Summer Time (BST)....

May 28, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Entrepreneurs with startups or business plans serving the baby boomer market are invited to apply to the 9th annual Silicon Valley Boomer Venture Summit and Business Plan Competition at SCU June 20.

May 28, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC) is pleased to announce that Etienne Veber has joined Precise Biometrics in the capacity of Chief Commercial Officer and Executive Vice President. He comes on board as part...

May 28, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics' (http://www.precisebiometrics.com)(STO:PREC) product for mobile security for smartphones and...

May 26, 2012

PHILADELPHIA--(BUSINESS WIRE)--Pre-diabetic patients who engage in regular aerobic exercise improve their vascular reactivity to nearly normal levels, even if no weight loss is achieved, according to research presented today at the American...

May 25, 2012

SEATTLE--(BUSINESS WIRE)--May 25, 2012--Dendreon Corporation (NASDAQ:DNDN) today announced that management will present at the following conferences: Jefferies 2012 Global Healthcare Conference in New York City on June 4, 2012, at 12:30 p.m. ET...

May 25, 2012

DUARTE, Calif.--(BUSINESS WIRE)--City of Hope has been awarded a $5 million grant to support the development of a T cell-based immunotherapy that re-directs a patient’s own immune response against glioma stem cells.

May 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that the Company will be conducting a webcast of the...

May 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex announces webcasts of its presentations at two investor conferences.

May 25, 2012

WASHINGTON--(BUSINESS WIRE)--BIO supports EPA's rejection of a petroleum industry petition to retroactively waive the 2011 Renewable Fuel Standard. The oil industry is using regulatory obstacles to keep the US dependent on oil.

May 25, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide insight on the upcoming release of its’ new over-the-...